Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 96,152 | 123,884 | 89,505 | 53,253 | 25,494 |
| Cost of Goods | 22,349 | 19,679 | 21,026 | 11,758 | 2,968 |
| Gross Profit | 73,803 | 104,205 | 68,479 | 41,487 | 22,534 |
| Operating Expenses | 75,537 | 43,760 | 39,697 | 45,627 | 19,201 |
| Operating Income | -1,385 | 61,124 | 28,808 | -3,374 | 4,293 |
| Interest Expense | 14,222 | 10,205 | 10,367 | 7,041 | 3,129 |
| Other Income | -19,107 | 374 | 71 | 264 | 294 |
| Pre-tax Income | -34,714 | 51,293 | 18,512 | -10,151 | 1,458 |
| Income Tax | -14,130 | 18,035 | 5,608 | N/A | 0 |
| Net Income Continuous | -20,584 | 33,258 | 12,904 | 143,008 | 1,458 |
| Net Income | $-20,584 | $33,258 | $12,904 | $143,008 | $1,458 |
| EPS Basic Total Ops | -0.62 | 1.09 | 0.47 | 6.39 | 0.07 |
| EPS Basic Continuous Ops | -0.62 | 1.09 | 0.47 | 6.39 | 0.07 |
| EPS Diluted Total Ops | -0.62 | 0.82 | 0.39 | 5.79 | 0.06 |
| EPS Diluted Continuous Ops | -0.62 | 0.77 | 0.34 | 5.72 | 0.06 |
| EBITDA(a) | $19,395 | $84,682 | $45,784 | $5,551 | $7,014 |